In a dexamethasone-induced obesity-related insulin resistance model, DHM significantly increases adipocyte insulin sensitivity by inhibiting ERK-mediated phosphorylation of the PPARγ serine 273 site, promotes glucose uptake, and reduces lipid accumulation (Liu et al., 2018b). This evidence concerns the gene INS and Insulin resistance.